Blackrock Health Sciences Trust (NYSE:BME) Coverage Initiated at Shore Capital

Stock analysts at Shore Capital initiated coverage on shares of Blackrock Health Sciences Trust (NYSE:BME) in a research note issued to investors on Friday, Stock Target Advisor reports. The brokerage set a “buy” rating and a $429.00 price target on the stock.

Shares of Blackrock Health Sciences Trust stock traded up $0.02 on Friday, reaching $39.13. 20,409 shares of the company were exchanged, compared to its average volume of 31,259. The stock has a fifty day moving average price of $38.28 and a 200-day moving average price of $38.12. Blackrock Health Sciences Trust has a fifty-two week low of $32.00 and a fifty-two week high of $42.49.

Institutional investors have recently made changes to their positions in the company. Mid Atlantic Financial Management Inc. ADV purchased a new position in shares of Blackrock Health Sciences Trust during the second quarter valued at $219,000. Doliver Advisors LP purchased a new position in shares of Blackrock Health Sciences Trust during the second quarter valued at $259,000. Cetera Advisors LLC purchased a new position in shares of Blackrock Health Sciences Trust during the third quarter valued at $348,000. Commonwealth Equity Services LLC grew its holdings in shares of Blackrock Health Sciences Trust by 17.1% during the second quarter. Commonwealth Equity Services LLC now owns 11,324 shares of the company’s stock valued at $440,000 after buying an additional 1,653 shares in the last quarter. Finally, Janney Montgomery Scott LLC grew its holdings in shares of Blackrock Health Sciences Trust by 2.1% during the third quarter. Janney Montgomery Scott LLC now owns 14,445 shares of the company’s stock valued at $553,000 after buying an additional 300 shares in the last quarter.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

About Blackrock Health Sciences Trust

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.

Featured Story: How does a reverse stock split work?

Stock Target Advisor

Leave a Reply

Your email address will not be published. Required fields are marked *

*